Integra LifeSciences Holdings (IART) — Strategic Asset Allocation Index
Integra LifeSciences Holdings (IART) has a Strategic Asset Allocation Index of 18.9% as of June 2023. Strategic assets (PP&E of $317.57 Million plus long-term investments of $-) total $317.57 Million, measured against net assets of $1.68 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Integra LifeSciences Holdings Strategic Asset Allocation Index (2000–2022)
This chart shows how Integra LifeSciences Holdings's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 18.9%, representing strategic assets of $317.57 Million against net assets of $1.68 Billion USD. Explore cash flow conversion of Integra LifeSciences Holdings to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Integra LifeSciences Holdings (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Integra LifeSciences Holdings from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Integra LifeSciences Holdings stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 17.3% | $311.30 Million | $311.30 Million | $- | $1.80 Billion | ▼ -1.2 pp |
| 2021 | 18.5% | $311.70 Million | $311.70 Million | $- | $1.68 Billion | ▼ -0.5 pp |
| 2020 | 19.0% | $287.53 Million | $287.53 Million | $- | $1.51 Billion | ▼ -4.8 pp |
| 2019 | 23.8% | $337.40 Million | $337.40 Million | $- | $1.42 Billion | ▲ +1.6 pp |
| 2018 | 22.2% | $305.46 Million | $300.11 Million | $5.35 Million | $1.38 Billion | ▼ -6.0 pp |
| 2017 | 28.2% | $271.74 Million | $269.25 Million | $2.49 Million | $962.31 Million | ▲ +1.6 pp |
| 2016 | 26.7% | $224.00 Million | $222.37 Million | $1.63 Million | $839.67 Million | ▼ -0.6 pp |
| 2015 | 27.3% | $205.18 Million | $205.18 Million | $- | $751.44 Million | ▼ -2.5 pp |
| 2014 | 29.8% | $209.99 Million | $209.99 Million | $- | $704.32 Million | ▼ -0.1 pp |
| 2013 | 29.9% | $200.31 Million | $200.31 Million | $- | $670.18 Million | ▼ -4.5 pp |
| 2012 | 34.4% | $177.90 Million | $177.90 Million | $- | $517.77 Million | ▲ +7.7 pp |
| 2011 | 26.7% | $131.38 Million | $131.38 Million | $- | $492.64 Million | ▲ +6.8 pp |
| 2010 | 19.9% | $99.46 Million | $99.46 Million | $- | $499.96 Million | ▲ +1.1 pp |
| 2009 | 18.8% | $83.53 Million | $83.53 Million | $- | $444.88 Million | ▼ -1.3 pp |
| 2008 | 20.1% | $70.38 Million | $70.38 Million | $- | $350.21 Million | ▼ -3.6 pp |
| 2007 | 23.7% | $61.73 Million | $61.73 Million | $- | $260.43 Million | ▲ +9.3 pp |
| 2006 | 14.4% | $42.56 Million | $42.56 Million | $- | $296.16 Million | ▲ +4.9 pp |
| 2005 | 9.5% | $27.45 Million | $27.45 Million | $- | $289.82 Million | ▲ +1.2 pp |
| 2004 | 8.3% | $25.46 Million | $25.46 Million | $- | $307.82 Million | ▲ +0.8 pp |
| 2003 | 7.5% | $20.07 Million | $20.07 Million | $- | $268.53 Million | ▲ +0.8 pp |
| 2002 | 6.7% | $16.56 Million | $16.56 Million | $- | $247.60 Million | ▲ +1.0 pp |
| 2001 | 5.7% | $11.66 Million | $11.66 Million | $- | $204.06 Million | ▼ -15.9 pp |
| 2000 | 21.6% | $11.60 Million | $11.60 Million | $- | $53.78 Million | — |